References
- Teasdale G, Mendelow D. Pathophysiology of head injuries. In: Brooks N, editor. Closed Head Injury. Psychological, Social and Family Consequences. Oxford: Oxford University Press; 1984. pp 5–36.
- Thornhill S, Teasdale GM, Murray GD, et al. Disability in young people and adults one year after head injury: Prospective cohort study. British Medical Journal 2000;320:1631–5.
- Mann RS. Differential diagnosis and classification of apathy. American Journal of Psychiatry 1990;147:22–30.
- Mann RS. Apathy: A neuropsychiatric syndrome. Journal of Neuropsychiatry & Clinical Neuroscience 1991;3:243–54.
- Mann RS, Firinciogullari S, Biedrzycki RC. The source of convergence between measures of apathy and depression. Journal of Affective Diseases 1993;28:117–24.
- Mann RS, Firinciogullari S, Biedrzycki RC. Group differ-ences in the relationship between apathy and depression. Journal of Nervous Mental Diseases 1994;182:235–9.
- Stuss DT, van Reekum R, Murphy KJ. Diferentiation of states and causes of apathy. In: Borod J, editor. Neuropsychology of Emotion. New York: Oxford University Press; 2000, pp 340–63.
- Mann RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Reseasrch 1991;38:143–62.
- Kant R, Duffy JD, Pivovamil A. Prevalence of apathy following head injury. Brain Injury, 1998;12:87–92.
- Mega MS, Cummings JL. Frontal cortical-subcortical circuits and neuropsychiatric disorder. Journal of Neuropsychiatry & Clinical Neuroscience 1994;6:358–70.
- Mann RS, Fogel BS, Hawkins J, et al. Apathy: A treatable syndrome. Journal of Neuropsychiatry & Clinical Neuroscience 1995;7:23–30.
- Kraus ME. Neuropsychiatric sequelae of stroke and traumatic brain injury: The role of psychostimulants. International Journal of Psychiatry Medicine 1995;25:39–51.
- Watanabe MD, Martin EM, Deleon OA, et al. Successful methylphenidate treatment of apathy after subcortical infarcts. Journal of Neuropsychiatry & Clinical Neuroscience 1995;7:502–4.
- Galynker I, Ieronimo C, Miner C, et al. Methylphenidate treatment of negative symptoms in patients with dementia. Journal of Neuropsychiatry & Clinical Neuroscience 1997;9:231–9.
- Glenn MB. Methylphenidate for cognitive and behavioural dysfunction after traumatic brain injury. Journal of Head Trauma Rehabilitation 1998;13:87–90.
- Plutchik L, Snyder S, Drooker M, et al. Methylphenidate in post liver transplant patients. Psychosomatics 1998; 39:118–23.
- Nickels JL, Schneider WN, Dombovy ML, et al. Clinical use of amantadine in brain injury rehabilitation. Brain Injury 1994;8:709–18.
- van Reekum R, Bayley M, Garner S, et al. N of 1 study: Amantadine for the arnotivational syndrome in a patient with traumatic brain injury. Brain Injury 1995;9:49–53.
- Zafonte RD, Watanabe T, Mann NR. Amantadine: A potential treatment for the minimally conscious state. Brain Injury 1998;12:617–21.
- Shiller AD, Burke DT, Kim HJ, et al. Treatment with amantadine potentiated motor learning in a patient with traumatic brain injury of 15 years duration. Brain Injury 1999;13:715–21.
- Kraus ME, Maki P. The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. Brain Injury 1997;11:455–60.
- Karli DC, Burke DT, Kim HJ, et al. Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury. Brain Injury 1999;13:63–8.
- Whyte J, Vaccaro M, Grieb-Neff P, et al. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. Journal of Head Trauma Rehabilitation 2002;17:284–99.
- Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind random-ized trial. Journal of Head Trauma Rehabilitation 2002;17:300–13.
- McDowell S, Whyte J, D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998;121:1155–64.
- Gualtieri CT. Psychostimulants, dopamine agonists and amantadine. In: Brain Injury and Mental Retardation. Philadelphia: Lippincott Williams & Wilkins; 2002. pp 301–22.
- Schaller JL, Behar D. Selegiline for the delivery of small doses of amphetamine. Journal of Neuropsychiatry & Clinical Neuroscience 1997;9:301-2.28. Zhu J, Hamm RJ, Reeves TM, et al. Post injury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Experimental Neurology 2000;166: 136–52.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington DC: American Psychiatric Association; 2000.
- Varney NR, Martzke JS, Roberts RJ. Major depression in patients with closed head injury. Neuropsychology 1987; 1:7–9.
- Jorge RE, Robinson RG, Arndt SV, et al. Depression and traumatic brain injury: A longitudinal study. Journal of Affective Disorders 1993;27:233–43.
- Kreutzer JS, Seel RT, Gourley E. The prevalence and symptom rates of depression after traumatic brain injury: A comprehensive examination. Brain Injury 2001;15:563–76.